Navigation Links
Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
Date:7/27/2009

to seek relief from their symptoms sooner."

Cryopraxis will also utilize C'elle stem cells to develop potential therapies for female stress urinary incontinence, a condition primarily caused by a deficiency in the muscles that affect urine flow. Since stem cells isolated from menstrual fluid have the ability to contract, research will determine whether injecting the cells into the urethra would restore the contractility of the muscles and sphincters.

"We are honored to partner with Cryopraxis, a global leader in regenerative medicine and stem cell R&D, to explore the utilization and potential commercialization of Cryo-Cell's proprietary C'elle menstrual stem cell technology in the future development of novel therapies for two debilitating conditions affecting women worldwide," said Mercedes A. Walton, Cryo-Cell's Chairman and CEO. "Millions of women may potentially benefit from the affordable and non-invasive collection of these valuable stem cells today with C'elle service, for the future possible treatment of these two conditions that are painful, pervasive and costly to treat."

The C'elle service is based on Cryo-Cell's expansive IP technology portfolio and was introduced in November, 2007 as the first and only service that empowers women to collect and cryopreserve menstrual flow containing undifferentiated adult stem cells for future potential utilization by the donor or possibly first-degree relatives in a manner similar to umbilical cord blood stem cells. Based on the continued success of MenSCs in the research setting, Cryo-Cell is actively expanding its portfolio of research collaborations with world renowned scientists committed to study this novel stem cell population for a broad range of regenerative therapeutic development.

About Cryopraxis Cryobiology Ltd.

Launched in 2001, Cryopraxis is primarily dedicated to stem cell and tissue banking. Cryopraxis is a l
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
2. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
3. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
4. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
5. AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
6. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
7. Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC
8. Elbit Imaging Ltd. Announces - Swiss Team Uses InSightecs ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders
9. Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris
10. Relievant Medsystems Announces Completion of $20 Million Financing
11. Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... FOREST, Ill. , March 6, 2015   Hospira, ... the U.S. Food and Drug Administration (FDA) on today,s FDA ... States . This is a watershed moment for improving ... As a leading global provider of biosimilars, Hospira has seen ... we are a proud participant in these early stages of ...
(Date:3/6/2015)... -- Aethlon Medical, Inc. (OTCQB:AEMD), the pioneer in developing targeted ... announced that James A. Joyce , Aethlon Medical ... at the 27th Annual ROTH Conference on March 10, ... scheduled to present at 5:30 pm Pacific on March ... The Ritz-Carlton Hotel in Laguna Niguel, California ...
(Date:3/6/2015)... , March 6, 2015 Troyen A. ... Officer of CVS Health (NYSE: CVS ), ... in Washington, D.C. today.  Brennan ... role in addressing health care cost and quality as ... making CVS/pharmacy the first national pharmacy chain to stop ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 2CVS Health Chief Medical Officer to Address National Business Group on Health on Value of Pharmacy Care in Evolving Health Care System 3
... , March 23 The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim ( Germany ) ... ... ... ...
... medical device companies, today announced it has been selected by the Advanced Medical Technology Association (AdvaMed), as a member of the organization,s Business Solutions Program. , ... , ... ... ...
Cached Medicine Technology:Novalung Records 50% Growth 2Novalung Records 50% Growth 3AdvaMed Selects Prolifiq as Member of Business Solutions Program 2AdvaMed Selects Prolifiq as Member of Business Solutions Program 3AdvaMed Selects Prolifiq as Member of Business Solutions Program 4
(Date:3/6/2015)... Pokemini ” was featured on NewsWatch as part of its ... on the iOS, Android, and Windows markets. Mallory Sofastaii, a ... review and shared with viewers how this is a fully ... years, mobile games have benefited from building in a social ... users to connect their games to Facebook, see what level ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Saving Moses, ... around the world is traveling to Angola, Africa March ... of their malnutrition program. , This will be the ... in Angola, demonstrating their commitment to the region’s population ... The team will engage with the mothers and babies ...
(Date:3/6/2015)... Ticket Down is a reputable source for authentic ... Center. After being away from the touring business for ... of letting up on his “Garth Brooks World Tour.” The ... Yearwood, to venues around the United States. The duo recently ... to the Moda Center in Portland, OR. The husband and ...
(Date:3/6/2015)... Jose, California (PRWEB) March 06, 2015 ... also known as the pharmacokinetics of a drug refers ... a pharmaceutical compound inside an organism. When toxicity studies ... ADME-Tox or ADMET or ADME/Tox. Increasing focus on lowering ... adoption of ADME-toxicology testing worldwide. The traditional drug development ...
(Date:3/6/2015)... 2015 As the Muscular Dystrophy Association ... the organization has hired two new Scientific Program Officers, ... will report to Grace Pavlath, Ph.D, who joined MDA ... Program Director, and together will lead MDA as it ... cures for various types of neuromuscular and motor neuron ...
Breaking Medicine News(10 mins):Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4
... ... offers a safe, gentle blend of natural active ingredients that provides temporary relief from common ... ... is in the air. This means itchy eyes, runny nose and sneeze-fests for millions of ...
... ... label. , ... (PRWEB) March 29, 2010 -- Advercan ( www.ADVERCAN.com ), 3M, and its sourcing ally, ... in 2007, and other interested media and beverage companies around Atlanta with very positive ...
... has positive effects, researchers say , MONDAY, March 29 (HealthDay ... people, Swedish researchers have found. , The study included 18 ... to cancer. They were offered a 25-minute hand or foot ... whether to have their massages at home, work or in ...
... ... are to offer Allergan implants as part of their standard breast augmentation package. ... (PRWEB) March 29, 2010 -- ... their ongoing attempt to provide the most comprehensive service to their patients having breast ...
... Payne Bolton School of Nursing at Case Western Reserve University ... cardiac rehabilitation program following a heart attack, bypass surgery or ... their hearts healthy. Women across the age ... comparison to men. Although all groups had a decline between ...
... , This release is available in ... may someday contain less fat and fewer calories, thanks ... as Mukti Singh. She,s based at the ARS National ... In experiments at her Peoria laboratory, Singh is ...
Cached Medicine News:Health News:New Natural Allergy Relief Available 2Health News:New Natural Allergy Relief Available 3Health News:Billions of Cleaner Beverage Can Tops Used as Billboard Space 2Health News:Rubicon Medical To Offer Allergan Implants In Breast Enlargement Surgery 2Health News:Study from CWRU Nursing School finds a year after cardiac event only 37 percent still exercising 2
... The Akbarnia PDR Instruments ... surgeons negotiate in and around ... and reconstruction procedures. The instruments ... construction, a variety of angled ...
... Concentrate System is a point-of-care system designed ... (also referred to as Platelet Rich Plasma ... from a small sample of blood. The ... factors, which are found in the platelets. ...
... II Platelet Concentrate System is a point-of-care ... Platelet Concentrate (also referred to as Platelet ... Plasma (PPP) from a small sample of ... body's natural growth factors, which are found ...
... Autologous growth factors (AGF) ... blood, the AGF gel delivers ... growth factors and proteins in ... the information of new bone ...
Medicine Products: